Fazeel M Siddiqui1, Sudeepta Dandapat2, Chirantan Banerjee2, Susanna M Zuurbier2, Mark Johnson2, Jan Stam2, Jonathan M Coutinho2. 1. From the Department of Neurology, Southern Illinois University School of Medicine, Springfield (F.M.S., S.D.); Department of Neurology, UT Southwestern Medical Center, Dallas, TX (F.M.S., C.B., M.J.); Department of Neurology, Academic Medical Hospital, University of Amsterdam, Amsterdam, The Netherlands (S.M.Z., J.S., J.M.C.); and Division of Neuroradiology, Department of Medical Imaging, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada (J.M.C.). fazeelmukhtar@gmail.com. 2. From the Department of Neurology, Southern Illinois University School of Medicine, Springfield (F.M.S., S.D.); Department of Neurology, UT Southwestern Medical Center, Dallas, TX (F.M.S., C.B., M.J.); Department of Neurology, Academic Medical Hospital, University of Amsterdam, Amsterdam, The Netherlands (S.M.Z., J.S., J.M.C.); and Division of Neuroradiology, Department of Medical Imaging, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada (J.M.C.).
Abstract
BACKGROUND AND PURPOSE: Cerebral venous thrombosis is generally treated with anticoagulation. However, some patients do not respond to medical therapy and these might benefit from mechanical thrombectomy. The aim of this study was to gain a better understanding of the efficacy and safety of mechanical thrombectomy in patients with cerebral venous thrombosis, by performing a systematic review of the literature. METHODS: We identified studies published between January 1995 and February 2014 from PubMed and Ovid. We included all cases of cerebral venous thrombosis in whom mechanical thrombectomy was performed with or without intrasinus thrombolysis. Good outcome was defined as normal or mild neurological deficits at discharge (modified Rankin Scale, 0-2). Secondary outcome variables included periprocedural complications and recanalization rates. RESULTS: Our study included 42 studies (185 patients). Sixty percent of patient had a pretreatment intracerebral hemorrhage and 47% were stuporous or comatose. AngioJet was the most commonly used device (40%). Intrasinus thrombolysis was used in 131 patients (71%). Overall, 156 (84%) patients had a good outcome and 22 (12%) died. Nine (5%) patients had no recanalization, 38 (21%) had partial, and 137 (74%) had near to complete recanalization. The major periprocedural complication was new or increased intracerebral hemorrhage (10%). The use of AngioJet was associated with lower rate of complete recanalization (odds ratio, 0.2; 95% confidence interval, 0.09-0.4) and lower chance of good outcome (odds ratio, 0.5; 95% confidence interval, 0.2-1.0). CONCLUSIONS: Our systematic review suggests that mechanical thrombectomy is reasonably safe but controlled studies are required to provide a definitive answer on its efficacy and safety in patients with cerebral venous thrombosis.
BACKGROUND AND PURPOSE:Cerebral venous thrombosis is generally treated with anticoagulation. However, some patients do not respond to medical therapy and these might benefit from mechanical thrombectomy. The aim of this study was to gain a better understanding of the efficacy and safety of mechanical thrombectomy in patients with cerebral venous thrombosis, by performing a systematic review of the literature. METHODS: We identified studies published between January 1995 and February 2014 from PubMed and Ovid. We included all cases of cerebral venous thrombosis in whom mechanical thrombectomy was performed with or without intrasinus thrombolysis. Good outcome was defined as normal or mild neurological deficits at discharge (modified Rankin Scale, 0-2). Secondary outcome variables included periprocedural complications and recanalization rates. RESULTS: Our study included 42 studies (185 patients). Sixty percent of patient had a pretreatment intracerebral hemorrhage and 47% were stuporous or comatose. AngioJet was the most commonly used device (40%). Intrasinus thrombolysis was used in 131 patients (71%). Overall, 156 (84%) patients had a good outcome and 22 (12%) died. Nine (5%) patients had no recanalization, 38 (21%) had partial, and 137 (74%) had near to complete recanalization. The major periprocedural complication was new or increased intracerebral hemorrhage (10%). The use of AngioJet was associated with lower rate of complete recanalization (odds ratio, 0.2; 95% confidence interval, 0.09-0.4) and lower chance of good outcome (odds ratio, 0.5; 95% confidence interval, 0.2-1.0). CONCLUSIONS: Our systematic review suggests that mechanical thrombectomy is reasonably safe but controlled studies are required to provide a definitive answer on its efficacy and safety in patients with cerebral venous thrombosis.
Authors: Leonard Ll Yeo; Priscillia Ps Lye; Kong Wan Yee; Yang Cunli; Tu Tian Ming; Andrew Fw Ho; Vijay K Sharma; Bernard Pl Chan; Benjamin Yq Tan; Anil Gopinathan Journal: Clin Neuroradiol Date: 2020-06-11 Impact factor: 3.649
Authors: Sudeepta Dandapat; Edgar A Samaniego; Viktor Szeder; Fazeel M Siddiqui; Gary R Duckwiler; Ume Kiddy; Waldo R Guerrero; Binbin Zheng; David Hasan; Colin Derdeyn; Santiago Ortega-Gutierrez Journal: Interv Neuroradiol Date: 2019-07-31 Impact factor: 1.610
Authors: Anderson Chun On Tsang; A C Hwang; R H Y Chiu; D Y C Chan; F C P Tsang; W S Ho; R Lee; G K K Leung; W M Lui Journal: Neuroradiology Date: 2018-08-21 Impact factor: 2.804
Authors: Jonathan M Coutinho; Susanna M Zuurbier; Marie-Germaine Bousser; Xunming Ji; Patricia Canhão; Yvo B Roos; Isabelle Crassard; Ana Paiva Nunes; Maarten Uyttenboogaart; Jian Chen; Bart J Emmer; Stefan D Roosendaal; Emmanuel Houdart; Jim A Reekers; René van den Berg; Rob J de Haan; Charles B Majoie; José M Ferro; Jan Stam Journal: JAMA Neurol Date: 2020-08-01 Impact factor: 18.302
Authors: John H Zhang; Andre Obenaus; David S Liebeskind; Jiping Tang; Richard Hartman; William J Pearce Journal: J Cereb Blood Flow Metab Date: 2017-09-19 Impact factor: 6.200